0.0000
-4.2600
(-100.00%)
As of May 30 at 8:52:31 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
58
58
477
1,352
1,015
Gross Profit
--
--
--
--
1,015
Operating Expense
8,059
8,059
12,121
13,253
13,645
Operating Income
-8,001
-8,001
-11,644
-11,901
-12,630
Net Non Operating Interest Income Expense
--
--
--
--
9
Other Income Expense
55
55
73
-6
7
Pretax Income
-7,946
-7,946
-11,571
-11,907
-12,623
Net Income Common Stockholders
-7,946
-7,946
-11,571
-11,907
-12,623
Diluted NI Available to Com Stockholders
-7,946
-7,946
-11,571
-11,907
-12,623
Basic EPS
-2.90
--
-8.19
-10.05
-11.25
Diluted EPS
-2.90
--
-8.19
-10.05
-11.25
Basic Average Shares
2,743.8280
--
1,411.9980
1,181.3980
1,127.8440
Diluted Average Shares
2,743.8280
--
1,411.9980
1,181.3980
1,127.8440
Total Operating Income as Reported
-8,001
-8,001
-11,644
-11,901
-12,630
Total Expenses
8,059
8,059
12,121
13,253
13,645
Net Income from Continuing & Discontinued Operation
-7,946
-7,946
-11,571
-11,907
-12,623
Normalized Income
-7,946
-7,946
-11,571
-11,907
-12,623
Interest Income
--
--
--
--
9
Net Interest Income
--
--
--
--
9
EBIT
-8,001
-8,001
-11,644
-11,901
-12,630
EBITDA
-7,934
-7,934
-11,560
-11,819
-12,570
Reconciled Depreciation
67
67
84
82
60
Net Income from Continuing Operation Net Minority Interest
-7,946
-7,946
-11,571
-11,907
-12,623
Normalized EBITDA
-7,934
-7,934
-11,560
-11,819
-12,570
12/31/2021 - 11/4/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0RU9.IL 0RU9.IL,0P0000KJ6A,0
1,147,190.00
0.00%
1HB0.F Scorpius Holdings, Inc.
0.0000
-100.00%
2KZ0.F Kezar Life Sciences, Inc.
3.5600
-11.00%
6DW.F D. Western Therapeutics Institute, Inc.
0.5550
-5.93%
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
2DE0.F Genprex, Inc.
0.0000
-100.00%
APH0.F Ampio Pharmaceuticals, Inc.
3.6200
0.00%
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
5LH0.F Guard Therapeutics International AB (publ)
1.0200
-2.86%
3EE0.F Kancera AB (publ)
0.0920
-7.91%